Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07447466
Eligibility Criteria:
Inclusion Criteria:
* specified singleton intrauterine pregnancies confirmed ultrasonographically
* gestational age between 14 and 28 weeks calculated from last menstrual period and corroborated by first-trimester ultrasound biometry
* absence of diagnosed musculoskeletal pathology requiring medical intervention
* medical clearance for moderate-intensity aerobic and resistance exercise from attending obstetricians
* capacity to commit to supervised exercise sessions six days weekly for six consecutive weeks
Exclusion Criteria:
* encompassed high-risk pregnancy classifications including placenta previa
* pregnancy-induced arterial hypertension or preeclampsia (systolic blood pressure ≥140 mmHg or diastolic ≥90 mmHg with proteinuria
* gestational diabetes mellitus requiring insulin therapy
* multiple gestation
* incompetent cervix or cerclage placement
* persistent second-trimester vaginal bleeding
* premature rupture of membranes
* history of preterm labor
* intrauterine growth restriction below tenth percentile
* contraindications to exercise per American College of Obstetricians and Gynecologists guidelines
* concurrent participation in structured exercise programs exceeding 60 minutes weekly
* acute lumbopelvic pain intensity exceeding six on numerical rating scale (0 to 10) necessitating pharmacological management
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT07447466
Study Brief:
Protocol Section:
NCT07447466